Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109

In the published publication [...]

Bibliographic Details
Main Authors: Albert Yu, Xiaoyong Dai, Zixian Wang, Huaqing Chen, Bing Guo, Laiqiang Huang
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biosensors
Subjects:
n/a
Online Access:https://www.mdpi.com/2079-6374/12/10/794
_version_ 1797474853075288064
author Albert Yu
Xiaoyong Dai
Zixian Wang
Huaqing Chen
Bing Guo
Laiqiang Huang
author_facet Albert Yu
Xiaoyong Dai
Zixian Wang
Huaqing Chen
Bing Guo
Laiqiang Huang
author_sort Albert Yu
collection DOAJ
description In the published publication [...]
first_indexed 2024-03-09T20:35:57Z
format Article
id doaj.art-67de6d599295497b9e76bde3e583e9fa
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-09T20:35:57Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-67de6d599295497b9e76bde3e583e9fa2023-11-23T23:10:46ZengMDPI AGBiosensors2079-63742022-09-01121079410.3390/bios12100794Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109Albert Yu0Xiaoyong Dai1Zixian Wang2Huaqing Chen3Bing Guo4Laiqiang Huang5Precision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaSchool of Science and Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Harbin Institute of Technology, Shenzhen 518055, ChinaPrecision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, ChinaIn the published publication [...]https://www.mdpi.com/2079-6374/12/10/794n/a
spellingShingle Albert Yu
Xiaoyong Dai
Zixian Wang
Huaqing Chen
Bing Guo
Laiqiang Huang
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
Biosensors
n/a
title Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
title_full Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
title_fullStr Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
title_full_unstemmed Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
title_short Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. <i>Biosensors</i> 2022, <i>12</i>, 109
title_sort correction yu et al recent advances of mesoporous silica as a platform for cancer immunotherapy i biosensors i 2022 i 12 i 109
topic n/a
url https://www.mdpi.com/2079-6374/12/10/794
work_keys_str_mv AT albertyu correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109
AT xiaoyongdai correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109
AT zixianwang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109
AT huaqingchen correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109
AT bingguo correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109
AT laiqianghuang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapyibiosensorsi2022i12i109